284 related articles for article (PubMed ID: 27129980)
1. Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial.
Jakobsson S; Huber D; Björklund F; Mooe T
BMC Cardiovasc Disord; 2016 Apr; 16():77. PubMed ID: 27129980
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study.
Jakobsson S; Irewall AL; Bjorklund F; Mooe T
BMC Cardiovasc Disord; 2015 Oct; 15():125. PubMed ID: 26466804
[TBL] [Abstract][Full Text] [Related]
3. Nurse-Led, Telephone-Based, Secondary Preventive Follow-Up after Stroke or Transient Ischemic Attack Improves Blood Pressure and LDL Cholesterol: Results from the First 12 Months of the Randomized, Controlled NAILED Stroke Risk Factor Trial.
Irewall AL; Ögren J; Bergström L; Laurell K; Söderström L; Mooe T
PLoS One; 2015; 10(10):e0139997. PubMed ID: 26474055
[TBL] [Abstract][Full Text] [Related]
4. Long-term, telephone-based follow-up after stroke and TIA improves risk factors: 36-month results from the randomized controlled NAILED stroke risk factor trial.
Ögren J; Irewall AL; Söderström L; Mooe T
BMC Neurol; 2018 Sep; 18(1):153. PubMed ID: 30241499
[TBL] [Abstract][Full Text] [Related]
5. Nurse-led, telephone-based secondary preventive follow-up benefits stroke/TIA patients with low education: a randomized controlled trial sub-study.
Irewall AL; Ögren J; Bergström L; Laurell K; Söderström L; Mooe T
Trials; 2019 Jan; 20(1):52. PubMed ID: 30646948
[TBL] [Abstract][Full Text] [Related]
6. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
Persell SD; Brown T; Lee JY; Shah S; Henley E; Long T; Luther S; Lloyd-Jones DM; Jean-Jacques M; Kandula NR; Sanchez T; Baker DW
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):560-6. PubMed ID: 26555123
[TBL] [Abstract][Full Text] [Related]
7. Nurse-led telephone-based follow-up of secondary prevention after acute coronary syndrome: One-year results from the randomized controlled NAILED-ACS trial.
Huber D; Henriksson R; Jakobsson S; Mooe T
PLoS One; 2017; 12(9):e0183963. PubMed ID: 28886083
[TBL] [Abstract][Full Text] [Related]
8. Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline.
Journath G; Hambraeus K; Hagström E; Pettersson B; Löthgren M
BMC Cardiovasc Disord; 2017 Aug; 17(1):224. PubMed ID: 28814290
[TBL] [Abstract][Full Text] [Related]
9. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
[TBL] [Abstract][Full Text] [Related]
10. Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.
Ergatoudes C; Thunström E; Rosengren A; Björck L; Bengtsson Boström K; Falk K; Fu M
BMC Cardiovasc Disord; 2016 Nov; 16(1):226. PubMed ID: 27855640
[TBL] [Abstract][Full Text] [Related]
11. Implementation of a telephone-based secondary preventive intervention after acute coronary syndrome (ACS): participation rate, reasons for non-participation and 1-year survival.
Huber D; Henriksson R; Jakobsson S; Stenfors N; Mooe T
Trials; 2016 Feb; 17():85. PubMed ID: 26876722
[TBL] [Abstract][Full Text] [Related]
12. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
[TBL] [Abstract][Full Text] [Related]
13. Long-term secondary prevention and outcome following acute coronary syndrome: real-world results from the Swedish Primary Care Cardiovascular Database.
Bentzel S; Ljungman C; Hjerpe P; Schiöler L; Manhem K; Bengtsson Boström K; Kahan T; Mourtzinis G
Eur J Prev Cardiol; 2024 May; 31(7):812-821. PubMed ID: 38135289
[TBL] [Abstract][Full Text] [Related]
14. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
[TBL] [Abstract][Full Text] [Related]
15. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).
Ota T; Ishii H; Suzuki S; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Tanaka A; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539
[TBL] [Abstract][Full Text] [Related]
16. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Pleiotropic Effects of Statins: A Reanalysis of the Randomized Trial Evidence Using Egger Regression-Brief Report.
Labos C; Brophy JM; Smith GD; Sniderman AD; Thanassoulis G
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):262-265. PubMed ID: 29122815
[TBL] [Abstract][Full Text] [Related]
18. Nurse-led, telephone-based follow-up after acute coronary syndrome yields improved risk factors after 36 months: the randomized controlled NAILED-ACS trial.
Henriksson R; Huber D; Mooe T
Sci Rep; 2021 Sep; 11(1):17693. PubMed ID: 34489516
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation.
Hajahmadi Pourrafsanjani M; Khayati Shal E; Khezrpour S
High Blood Press Cardiovasc Prev; 2019 Feb; 26(1):37-43. PubMed ID: 30684247
[TBL] [Abstract][Full Text] [Related]
20. Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry.
Lowenstern A; Li S; Navar AM; Virani S; Lee LV; Louie MJ; Peterson ED; Wang TY
Am Heart J; 2018 Jun; 200():118-124. PubMed ID: 29898839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
